Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Oct
07
Today In Oncology
Use of Obecabtagene Autoleucel CAR T-Cell Therapy for B-Cell Acute Lymphocytic Leukemia
Immunotherapy Addition Yields QOL Benefits in Limited-Stage Small Cell Lung Cancer
Can Nicotinamide Lessen the Risk of Skin Cancer Development
More Tattoos, Lessened Risk of Melanoma? New Study Investigates
Patient-Reported Outcomes and Overall Survival in Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo